s6y

Nemaura Medical Inc.

CIK
1602078
Industry
Surgical & Medical Instruments & Apparatus

Financials 47

  1. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Mar 31, 2024
  2. 10-Q Quarterly Report for period ending Dec 31, 2023
  3. 10-Q Quarterly Report for period ending Sep 30, 2023
  4. 10-Q Quarterly Report for period ending Jun 30, 2023
  5. 10-K/A Annual Report for period ending Mar 31, 2023
  6. 10-K Annual Report for period ending Mar 31, 2023
  7. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Mar 31, 2023
  8. 10-Q Quarterly Report for period ending Dec 31, 2022
  9. 10-Q/A Quarterly Report for period ending Sep 30, 2022
  10. 10-Q/A Quarterly Report for period ending Jun 30, 2022

All 47 financials filings

News 125

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 125 news filings

Ownership 27

  1. SC 13G Major Shareholders
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 27 ownership filings

Prospectus 26

  1. 424B8 Prospectus filed pursuant to Rule 424(b)(8)
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. S-1/A General form of registration statement for all companies including face-amount certificate companies
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. S-3 Registration statement for specified transactions by certain issuers
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 26 prospectus filings

Proxies 16

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14C Definitive information statements
  10. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

All 16 proxies filings

Other 35

  1. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  2. EFFECT Notice of Effectiveness
  3. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  4. EFFECT Notice of Effectiveness
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. EFFECT Notice of Effectiveness

All 35 other filings